Beth C Seidenberg Sagimet Biosciences Inc. (SGMT) insider trading activity

SGMT Quotes by TradingView

BETH C SEIDENBERG Transaction History

Date Transaction Value Shares Traded Form
Jul 18 2023
SELL
Sale (or disposition) back to the issuer
-
38,763
Jul 18 2023
BUY
Conversion of derivative security
-
1,860,712
Jul 18 2023
BUY
Grant, award, or other acquisition
-
38,763
Jul 18 2023
BUY
Open market or private purchase
$750,000 $16.0 p/Share
46,875

Also insider at

PGNY
Progyny, Inc. Healthcare
Director
VERA
Vera Therapeutics, Inc. Healthcare
ATRA
Atara Biotherapeutics, Inc. Healthcare
SLRN
ACELYRIN, Inc.
Director
KYTX
Kyverna Therapeutics, Inc.
BCS

Beth C Seidenberg

Director
New York, NY

Track Institutional and Insider Activities on SGMT

Follow Sagimet Biosciences Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMT shares.

Notify only if

Insider Trading

Get notified when an Sagimet Biosciences Inc. insider buys or sells SGMT shares.

Notify only if

News

Receive news related to Sagimet Biosciences Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGMT